| Dr Nagy Shanawany, MD | |
|
312 S Lake St, Leesburg, FL 34748-5934 | |
| (352) 314-9300 | |
| Not Available |
| Full Name | Dr Nagy Shanawany |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 57 Years |
| Location | 312 S Lake St, Leesburg, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912911975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | ME49250 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fakhoury Medical And Chiropractic Center Pllc | 8628116464 | 7 |
News Archive
Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced the launch of two new online destinations www.PodiatristSites.com and www.LocalPhysician.com as the company seeks to expand its portfolio of health related online destinations.
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.
Three new HealthPartners Research Foundation studies will examine ways to prevent and treat childhood obesity and hypertension. One study will look at interventions to prevent obesity in children ages 5-9, another will focus on obesity prevention in children ages 2-5, while another will examine hypertension in children and adolescents, including the quality and cost of care.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that Allos Therapeutics' new international disease-specific registry for patients with peripheral T-cell lymphoma (PTCL) has enrolled its first study participant.
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.
› Verified 8 days ago
| Entity Name | Fakhoury Medical & Chiropractic Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144458480 PECOS PAC ID: 8628116464 Enrollment ID: O20091116000184 |
News Archive
Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced the launch of two new online destinations www.PodiatristSites.com and www.LocalPhysician.com as the company seeks to expand its portfolio of health related online destinations.
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.
Three new HealthPartners Research Foundation studies will examine ways to prevent and treat childhood obesity and hypertension. One study will look at interventions to prevent obesity in children ages 5-9, another will focus on obesity prevention in children ages 2-5, while another will examine hypertension in children and adolescents, including the quality and cost of care.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that Allos Therapeutics' new international disease-specific registry for patients with peripheral T-cell lymphoma (PTCL) has enrolled its first study participant.
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nagy Shanawany, MD 1109 Sw 10th St, Ocala, FL 34474-2725 Ph: (352) 629-3433 | Dr Nagy Shanawany, MD 312 S Lake St, Leesburg, FL 34748-5934 Ph: (352) 314-9300 |
News Archive
Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced the launch of two new online destinations www.PodiatristSites.com and www.LocalPhysician.com as the company seeks to expand its portfolio of health related online destinations.
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.
Three new HealthPartners Research Foundation studies will examine ways to prevent and treat childhood obesity and hypertension. One study will look at interventions to prevent obesity in children ages 5-9, another will focus on obesity prevention in children ages 2-5, while another will examine hypertension in children and adolescents, including the quality and cost of care.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that Allos Therapeutics' new international disease-specific registry for patients with peripheral T-cell lymphoma (PTCL) has enrolled its first study participant.
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.
› Verified 8 days ago
Gregory S Krivonyak, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 E Dixie Ave, Leesburg, FL 34748 Phone: 352-323-2273 Fax: 352-323-2261 |